| The Eyedoctors | |
|
2600 Iowa St, Lawrence, KS 66046-4152 | |
| (636) 200-4393 | |
| (785) 842-1291 |
| Full Name | The Eyedoctors |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2600 Iowa St, Lawrence, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235108101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | KS 1596 (Kansas) | Primary |
| Provider Name | Brian J Horsch |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1649251596 PECOS PAC ID: 8527951276 Enrollment ID: I20040209000761 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
| Provider Name | Kyle R Bechtold |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609880517 PECOS PAC ID: 5496758013 Enrollment ID: I20060821000036 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
| Provider Name | Erin E Hamilton |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285820621 PECOS PAC ID: 0244311090 Enrollment ID: I20080426000042 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
| Provider Name | Angela M Macdonald |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1881894046 PECOS PAC ID: 4880782739 Enrollment ID: I20100309000194 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
| Provider Name | Jayme A Brown |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1568776003 PECOS PAC ID: 8123143971 Enrollment ID: I20100916000581 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
| Provider Name | Jessica K Putnam |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184971087 PECOS PAC ID: 6204084056 Enrollment ID: I20120919000793 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| The Eyedoctors Po Box 207293, Dallas, TX 75320-7255 Ph: (636) 200-4393 | The Eyedoctors 2600 Iowa St, Lawrence, KS 66046-4152 Ph: (636) 200-4393 |
News Archive
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.
Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
› Verified 6 days ago
Kevin K Trummel, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3111 W 6th St, Lawrence, KS 66049 Phone: 785-841-5288 Fax: 785-749-2323 | |
Dr. Brent T. Crandon & Dr. Elizabeth J. Crandon Optometrists Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1019 Massachusetts St, Lawrence, KS 66044 Phone: 785-843-3844 Fax: 785-331-2496 | |
Mrs. Lauren Nicole Bynorth, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 831 Vermont St, Lawrence, KS 66044 Phone: 785-843-5655 Fax: 785-841-3153 | |
Professional Eyecare Management Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3201 S Iowa St, Lawrence, KS 66046 Phone: 785-383-3417 | |
The Eyedoctors Optometrist Medicare: Not Enrolled in Medicare Practice Location: 935 Iowa St Ste 3, Lawrence, KS 66044 Phone: 636-200-4393 | |
Arliss L Stebbins, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3111 W 6th St, Lawrence, KS 66049 Phone: 785-841-5288 Fax: 785-749-2323 | |
Dr. Sharon M Green, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3111 W 6th St, Lawrence, KS 66049 Phone: 785-841-5288 Fax: 785-749-2323 |